Paula M Luz

Author PubWeight™ 17.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One 2013 1.46
2 Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 2009 1.32
3 Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010 1.30
4 Dengue infection increases the locomotor activity of Aedes aegypti females. PLoS One 2011 1.16
5 Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore. J Acquir Immune Defic Syndr 2011 1.04
6 Genomic rearrangements and transcriptional analysis of the spliced leader-associated retrotransposon in RNA interference-deficient Trypanosoma brucei. Mol Microbiol 2007 1.04
7 Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface 2007 1.03
8 Incidence of modifying or discontinuing first HAART regimen and its determinants in a cohort of HIV-infected patients from Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2010 1.01
9 The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat 2009 1.01
10 Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study. BMC Infect Dis 2009 0.96
11 Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997-2011. BMC Infect Dis 2014 0.92
12 Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS 2015 0.90
13 Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine 2013 0.89
14 Incidence and determinants of severe morbidity among HIV-infected patients from Rio de Janeiro, Brazil, 2000-2010. Antivir Ther 2014 0.83
15 A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Res Hum Retroviruses 2015 0.83
16 H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses. PLoS One 2012 0.79
17 Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America. AIDS Behav 2015 0.79
18 Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. BMC Infect Dis 2014 0.77
19 30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2017 0.75